Analytical Data
-
基因名
Slc7a10
- Application
-
别名
Slc7a10；ASC1；Asc-type amino acid transporter 1
-
种属
Mouse
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P63115
-
表达区间
1-530aa
-
氨基酸序列
MRRDSDMASHIQQPGGHGNPGPAPSPSPGPGPGPGASERVALKKEIGLVSACTIIIGNIIGSGIFISPKGVLEHSGSVGLALFVWVLGGGVTALGSLCYAELGVAIPKSGGDYAYVTEIFGGLAGFLLLWSAVLIMYPTSLAVISMTFSNYVLQPVFPNCIPPATASRVLSMACLMLLTWVNSSSVRWATRIQVIFTGGKLLALSLIITVGFVQIFQGHFEELRPTNAFAFWMTPSVGHLALAFLQGSFAFSGWNFLNYVTEELVDPRKNLPRAIFISIPLVTFVYTFTNVAYFTAMSPQELLSSNAVAVTFGEKLLGYFSWVMPVSVALSTFGGINGYLFTSSRLCFSGAREGHLPSFLAMIHVRRCTPIPALLVCCGATAVIMLVGDTYTLINYVSFINYLCYGVTILGLLVLRWRRPALHRPIKVNLLVPVVYLVFWAFLLVFSFISEPMVCGVGIIIILTGVPIFFLGVFWRSKPKCVHRFTESMTRWGQELCFVVYPQGSLEEEENGPMGQPSPLPITDKPLKTQ
-
分子量
57.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Slc7a10, a member of the solute carrier family, is recognized for its role as a proton-coupled amino acid transporter, specifically facilitating the transport of neutral amino acids across cell membranes. It has garnered attention due to its implications in various physiological processes, including neurotransmission, metabolic regulation, and cellular signaling. Abnormal expression or function of Slc7a10 has been linked to several neurological disorders, such as schizophrenia and depression, highlighting its potential as a therapeutic target. Recent advances in recombinant protein technology have enabled the production and characterization of Slc7a10, allowing researchers to investigate its structural and functional properties in detail. These studies aim to elucidate the transport mechanisms and substrate specificity of the protein, providing insights into its biological significance. Furthermore, understanding the structure-function relationships of Slc7a10 could facilitate the development of small molecules or inhibitors that modulate its activity, offering new avenues for pharmacological intervention in related disorders. Thus, research on Slc7a10 recombinant proteins not only deepens our understanding of amino acid transport but also paves the way for novel therapeutic strategies in treating psychiatric and neurological conditions.
